JENNIFER JIMENEZ: Open Payments
NPI 1346586112 · UNION MILLS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,903 in 73 payments from 16 companies in 2025. Trend: 2023 $16,402 · 2024 $7,825 · 2025 $2,903
Food & beverage: $2,903
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $678 |
| Axsome Therapeutics, Inc. | 9 | $509 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $297 |
| Neurocrine BioSciences, Inc. | 7 | $291 |
| Otsuka America Pharmaceutical, Inc. | 5 | $265 |
| Alkermes, Inc. | 4 | $237 |
| ABBVIE INC. | 6 | $177 |
| Corium, LLC | 4 | $128 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| Almatica Pharma LLC | 3 | $69 |
Products named: UZEDY, Auvelity, CAPLYTA, REXULTI, INGREZZA, VRAYLAR, Azstarys, ARISTADA.
Industry payments across IN — which companies pay providers there.
